PROTAC Akt3 Degrader-1
PROTAC Akt3 Degrader-1 is a highly efficient and selective PROTAC degrader targeting Akt3. PROTAC Akt3 Degrader-1 shows weak antiproliferative activity in 36 cell lines. PROTAC Akt3 Degrader-1 can be used for the study of Triple-negative breast cancer and melanoma[1].
Product Specifications
CAS Number
3048204-93-6
UNSPSC
12352005
Target
Akt; PROTACs
Related Pathways
PI3K/Akt/mTOR; PROTAC
Field of Research
Cancer
Smiles
O=C1NC2=NC=NC(N3[C@H]4C[C@H]4N(CC3)C([C@@H](C5=CC=C(C=C5)Cl)CNC(CCCCCCCCCCC6=C(C7=CC=C6)CN(C7=O)C8CCC(NC8=O)=O)=O)=O)=C2[C@@H](C1)C
Molecular Formula
C46H55ClN8O6
Molecular Weight
851.43
References & Citations
[1]Wu YB, et al. Design, Synthesis, and Biological Evaluation of Isoform-Selective Akt3 Degraders. J Med Chem. 2025 Sep 11;68 (17) :18272-18288.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Akt3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470977-500 1x 500 µL
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880965-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681870-100 1x 100 µL
CD10 (Membrane Metalloendopeptidase) (MME/1870), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details